Market cap
₹14 Cr
Revenue (TTM)
₹8 Cr
P/E Ratio
--
P/B Ratio
-0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0 %
-
ROCE
-10.1 %
-
Industry P/E
33.99
-
EV/EBITDA
70.9
-
Debt to Equity
-1.5
-
Book Value
₹-15.5
-
EPS
₹-0.4
-
Face value
10
-
Shares outstanding
10,000,700
10 Years Aggregate
CFO
₹-1.63 Cr
EBITDA
₹-5.27 Cr
Net Profit
₹-20.16 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Norris Medicines
| -10.5 | 0.1 | 7.7 | -10.9 | 5.4 | 9.2 | -- |
|
BSE Healthcare*
| 17.7 | 0.7 | 10.1 | 16.8 | 22.6 | 14.0 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Norris Medicines
| -6.2 | 26.0 | -1.9 | 29.7 | 71.3 | 59.0 | -19.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Norris Medicines
|
14.3 | 14.3 | 7.6 | -0.4 | 0.0 | -- | -- | -0.9 |
| 6,879.5 | 17,317.8 | 2,432.1 | 169.6 | 8.7 | 20.8 | 102.1 | 19.2 | |
| 2,684.9 | 20,606.4 | 2,287.3 | 678.1 | 31.4 | 19.7 | 31 | 5.5 | |
| 2,068.4 | 12,486.4 | 1,479.1 | 198.6 | 18.6 | 30.3 | 62.7 | 15.5 | |
| 1,281.1 | 17,989.5 | 3,229.7 | 666.9 | 26.6 | 18.8 | 27.9 | 4.4 | |
| 4,636.6 | 21,329.9 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29 | 4.8 | |
| 5,730.0 | 9,598.8 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.9 | 15.6 | |
| 3,181.9 | 7,254.2 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.4 | 8.8 | |
| 913.6 | 17,391.1 | 1,682.5 | 273.5 | 21.0 | 11.1 | 58.5 | 6.5 | |
| 1,021.4 | 9,433.0 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.4 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Norris Medicines
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
1990
-
Chairman
--
-
Managing Director
--
-
Headquarters
Ankleshwar, Gujarat
-
Website
FAQs for Norris Medicines
What is the current share price of Norris Medicines Ltd Today?
The share price of Norris Medicines Ltd is ₹14.27 (BSE) as of 01-Sep-2026 IST. Norris Medicines Ltd has given a return of 5.45% in the last 3 years.
What is the current PB & PE ratio of Norris Medicines Ltd?
Since, TTM earnings of Norris Medicines Ltd is negative, P/E ratio is not available.
The P/B ratio of Norris Medicines Ltd is -0.92 times as on 01-Sep-2026, a 117 discount to its peers’ median range of 5.29 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
-1.12 |
2024 |
0.00 |
-0.99 |
2023 |
0.00 |
-0.83 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
-0.87 |
What is the 52 Week High and Low of Norris Medicines Ltd?
The 52-week high and low of Norris Medicines Ltd are Rs 19.63 and Rs 12.00 as of 02-Sep-2026.
What is the market cap of Norris Medicines Ltd?
Norris Medicines Ltd has a market capitalisation of ₹ 14 Cr as on 01-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Norris Medicines Ltd?
Before investing in Norris Medicines Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.